OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial



[
OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial
[og_img]
https://www.investing.com/news/company-news/okyo-pharma-receives-fda-feedback-on-phase-3-neuropathic-pain-trial-93CH-4781282


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img